Insider Trading July 8, 2026 05:27 PM

Ibotta: Clark Jermoluk Founders Fund I Sells $15.1M in Stock

Ten percent owner liquidates half a million shares as Ibotta trades near recent highs, following a quarter where revenue slightly exceeded guidance despite an EPS miss.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
IBTA

Clark Jermoluk Founders Fund I LLC, a significant ten percent shareholder in Ibotta, Inc. (NASDAQ:IBTA), executed a substantial divestment of its holdings in early July 2026. The fund sold 500,000 shares of Ibotta's Class A Common Stock on July 6, 2026, at an average price of $30.15 per share. This transaction resulted in a total realized value of approximately $15.08 million. The sale occurs against a backdrop of Ibotta's stock performance, which has seen a 52% appreciation over the preceding six months, with the stock currently trading at $31.19. Despite this recent rally, analysis from InvestingPro suggests that Ibotta's stock may remain undervalued relative to its calculated Fair Value, indicating that potential upside could still exist for the equity. James H. Clark, who is also a ten percent owner and linked to the fund, was identified as the reporting owner for this specific transaction. The shares involved in the sale are held directly by Clark Jermoluk Founders Fund I LLC, which is structured such that 95% of the fund is owned by the JHC Trust. Mr. Clark has formally disclaimed beneficial ownership of the shares held within the fund, except to the degree of his pecuniary interest therein. Following the completion of this sale, Clark Jermoluk Founders Fund I LLC retains a direct position of 3,341,308 shares of Ibotta, Inc. Class A Common Stock.

Ibotta: Clark Jermoluk Founders Fund I Sells $15.1M in Stock
IBTA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Clark Jermoluk Founders Fund I LLC liquidated 500,000 shares of Ibotta Inc. (NASDAQ:IBTA) for approximately $15.08 million, reducing its direct holdings to 3,341,308 shares.
  • Ibotta reported a significant earnings miss in Q1 2026 with an EPS of $0.24 versus the $0.62 forecast, yet revenue of $82.5 million slightly beat internal guidance despite a 2% year-over-year decline.
  • Needham upgraded its price target for Ibotta to $45 from $33, citing a higher target multiple, while noting the company has beaten the top end of guidance for three consecutive quarters.

Clark Jermoluk Founders Fund I LLC, a ten percent owner of Ibotta, Inc. (NASDAQ:IBTA), sold 500,000 shares of the company's Class A Common Stock on July 6, 2026. The transaction was executed at a price of $30.15 per share, resulting in a total value of approximately $15.08 million. The sale comes as Ibotta's stock has surged 52% over the past six months, currently trading at $31.19. According to InvestingPro analysis, the stock appears undervalued relative to its Fair Value, suggesting potential upside remains despite the recent rally.

James H. Clark, also a ten percent owner and associated with Clark Jermoluk Founders Fund I LLC, was listed as a reporting owner for this transaction. The shares are held directly by Clark Jermoluk Founders Fund I LLC, which is 95% owned by the JHC Trust. Mr. Clark disclaims beneficial ownership of the shares held by Clark Jermoluk Founders Fund I LLC, except to the extent of his pecuniary interest therein.

Following this sale, Clark Jermoluk Founders Fund I LLC directly holds 3,341,308 shares of Ibotta, Inc. Class A Common Stock.

In other recent news, Ibotta Inc. reported its Q1 2026 earnings, revealing a notable miss in earnings per share (EPS) compared to forecasts. The company posted an EPS of $0.24, which fell short of the anticipated $0.62, representing a 61.29% surprise miss. Despite this earnings miss, Ibotta's revenue for the quarter reached $82.5 million, slightly exceeding internal guidance, though it marked a 2% decline from the previous year. Additionally, Needham raised its price target for Ibotta to $45 from $33 while maintaining a Buy rating. The firm cited a higher target multiple as the reason for the increase, although it modestly lowered estimates for 2026. Ibotta has consistently surpassed the top end of guidance for three consecutive quarters after initially underperforming post-IPO. These developments highlight the company's ongoing efforts to navigate its financial landscape amidst market expectations.

Risks

  • The company faces the risk of continued earnings volatility, as evidenced by a 61.29% surprise miss in Q1 2026 EPS, which could impact investor confidence and valuation multiples in the consumer discretionary sector.
  • Revenue growth has slowed, with a 2% year-over-year decline in Q1 2026, posing a risk to the sustainability of Ibotta's market position and future pricing power within the digital advertising and cashback platform industry.

More from Insider Trading

Meta Platforms COO Javier Olivan Executes $3.15 Million Share Sale Under Pre-Arranged Trading Plan Jul 8, 2026 BillionToOne CEO Atay Oguzhan Executes $4.7M Share Sale Under Pre-Arranged Plan Jul 8, 2026 Snowflake Director Michael L Speiser Offloads $12.2M in Stock Under Pre-Arranged Plan Jul 8, 2026 Palisade Bio Director Robert Baltera Jr. Expands Stake with $102K Share Purchase Jul 8, 2026 Palisade Bio Executive Offloads Shares to Meet Tax Obligations Amid Clinical Milestones Jul 8, 2026